One Eleven Interactive, Inc

Innovative marketing programs for the pharmaceutical industry

One Eleven Interactive, Inc Pharmaceuticals Ultraagenyx Pharmaceuticals stocks up on ‘historic’ milestone

Ultraagenyx Pharmaceuticals stocks up on ‘historic’ milestone



Ultraagenys shares are soaring as its blockbuster drug to treat lung cancer reached its milestone milestone.

Ultraagenyx Pharma shares jumped more than 12% after the drug’s release.

The drug is the first to hit the market with a gene therapy and was the most expensive in history, at $1.5 billion.

Ultraengys stock is up more than 30% so far this year.

TopBack to Top